A recent case study conducted by researchers at the Federal University of Santa Catarina in Brazil suggests that cannabis oil, specifically full-spectrum CBD oil, may offer a viable alternative treatment for dogs suffering from discoid lupus erythematosus (DLE), a common autoimmune skin disease.
Published in the journal Frontiers in Veterinary Science, the study detailed the case of a two-year-old dog experiencing adverse effects from conventional steroid therapies typically used to treat DLE. Upon administering a full-spectrum oil with a 2:1 THC:CBD ratio orally, the researchers observed significant improvement in the dog’s dermatological symptoms, alongside an improvement in liver function.
Notably, the dog’s owner reported positive changes in the dog’s behavior shortly after discontinuing prednisolone and initiating cannabis oil treatment. The researchers highlighted the benefits of cannabis derivatives in managing inflammation and immune system dysregulation, particularly through interaction with the body’s endocannabinoid system.
Unlike corticosteroids, which are limited to short-term use due to potential side effects, cannabis products were deemed safe for long-term usage with minimal adverse effects. Throughout the treatment period, the dog maintained overall well-being and showed a stabilization of dermatological signs without the need for corticoids.
While acknowledging the promising results, the researchers emphasized the necessity for further research to establish optimal dosing and long-term efficacy of cannabinoid therapy for DLE in dogs.
The study contributes to a growing body of research exploring the therapeutic potential of cannabis products for various animal ailments. Recent studies have shown CBD’s effectiveness in reducing stress and anxiety in dogs during car travel, as well as alleviating symptoms of arthritis and seizures.
However, regulatory agencies like the Food and Drug Administration (FDA) have raised concerns about the lack of data regarding the safety of CBD products for animals, particularly in terms of potential residues in food products derived from CBD-treated animals.
Despite regulatory scrutiny, interest in exploring the therapeutic benefits of cannabis for animals remains high, with ongoing research aimed at expanding understanding and usage in veterinary medicine. As the chorus of evidence grows, cannabis therapy could offer a promising avenue for managing challenging diseases like DLE in dogs, providing hope for improved quality of life and alternative treatment options.
Read the whole article here.
